dutch medical tech firm philips posted a nine percent jump in secondquarter sales and a return to profit on monday as it bounces back from a global recall of sleep respirators the amsterdambased company said sales rose to 45 billion euros 49 billion it reported a net profit of 74 million euros following a loss of 20 million euros over the same period last year i am pleased with our improved operational performance across all segments and geographies in the quarter philips chief executive roy jakobs said the medical device maker in 2021 announced a major recall of its dreamstation machines for sleep apnoea a disorder in which breathing stops and starts during sleep users were said to be at risk of inhaling or swallowing pieces of toxic soundproofing foam that could cause irritation or headaches philips also mentioned a potential cancer risk in the long term but it announced in may that independent tests showed the sleep respirators at the centre of the massive recall were unlikely to harm patients the replacement of suspected faulty devices had almost been complete with the vast majority of the sleep devices now back with patients and home care providers jakobs said we are fully focused on the remediation of the affected ventilators he said the recall hit the 132yearold company hard and by january it announced it was slashing 10000 jobs out of a total workforce of just under 80000 employees around the globe to date philips has cut 6600 jobs out of the planned total set for 2025 the company said philips has faced a us department of justice probe over the respirator issue and was negotiating with us authorities over a financial settlement it is also a defendant in several class action lawsuits in the united states and other litigation elsewhere while uncertainties remain philips said it expected sales to grow in the midsingledigits for the rest of the year the outlook however excludes the impact of ongoing litigation and the us investigation it said